{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:41:33Z","timestamp":1776901293027,"version":"3.51.2"},"publisher-location":"New York, NY","reference-count":17,"publisher":"Springer US","isbn-type":[{"value":"9781071651971","type":"print"},{"value":"9781071651988","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5198-8_4","type":"book-chapter","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:03:43Z","timestamp":1776899023000},"page":"47-58","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of In Vitro Potency Assays for Gene Therapy Products Targeting cGMP-Related Retinopathies"],"prefix":"10.1007","author":[{"given":"Marina","family":"Pavlou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stylianos","family":"Michalakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"4_CR1","doi-asserted-by":"crossref","unstructured":"Michalakis S, Gerhardt M, Rudolph G, Priglinger S, Priglinger C (2022) Achromatopsia: genetics and gene therapy. Mol Diagn Ther [Internet]. [cited 2022 Feb 16];26(1):51. Available from: \/pmc\/articles\/PMC8766373\/","DOI":"10.1007\/s40291-021-00565-z"},{"key":"4_CR2","doi-asserted-by":"crossref","unstructured":"Michalakis S, Becirovic E, Biel M (2018) Retinal cyclic nucleotide-gated channels: from pathophysiology to therapy. Int J Mol Sci [Internet]. [cited 2021 Feb 18];19(3):749. Available from: www.rcsb.org\/3d-view\/","DOI":"10.3390\/ijms19030749"},{"key":"4_CR3","doi-asserted-by":"crossref","unstructured":"Kom\u00e1romy AM, Rowlan JS, Corr ATP, Reinstein SL, Boye SL, Cooper AE, et al (2013) Transient photoreceptor deconstruction by CNTF enhances rAAV-mediated cone functional rescue in late stage CNGB3-achromatopsia. Mol Ther [Internet]. [cited 2022 Feb 16];21(6):1131. Available from: \/pmc\/articles\/PMC3677296\/","DOI":"10.1038\/mt.2013.50"},{"key":"4_CR4","doi-asserted-by":"crossref","unstructured":"Kom\u00e1romy AM, Alexander JJ, Rowlan JS, Garcia MM, Chiodo VA, Kaya A, et al (2010) Gene therapy rescues cone function in congenital achromatopsia. Hum Mol Genet [Internet]. [cited 2022 Feb 16];19(13):2581\u201393. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20378608\/","DOI":"10.1093\/hmg\/ddq136"},{"key":"4_CR5","doi-asserted-by":"crossref","unstructured":"Michalakis S, M\u00fchlfriedel R, Tanimoto N, Krishnamoorthy V, Koch S, Fischer MD, et al (2010) Restoration of cone vision in the CNGA3\u2212\/\u2212 mouse model of congenital complete lack of cone photoreceptor function. Mol Ther [Internet]. [cited 2020 Mar 25];18(12):2057\u201363. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20628362\/","DOI":"10.1038\/mt.2010.149"},{"key":"4_CR6","doi-asserted-by":"crossref","unstructured":"Carvalho LS, Xu J, Pearson RA, Smith AJ, Bainbridge JW, Morris LM, et al (2011) Long-term and age-dependent restoration of visual function in a mouse model of CNGB3-associated achromatopsia following gene therapy. Hum Mol Genet [Internet]. [cited 2022 Feb 16];20(16):3161\u201375. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21576125\/","DOI":"10.1093\/hmg\/ddr218"},{"key":"4_CR7","doi-asserted-by":"crossref","unstructured":"Pang J jing, Deng WT, Dai X, Lei B, Everhart D, Umino Y, et al (2012) AAV-mediated cone rescue in a naturally occurring mouse model of CNGA3-achromatopsia. PLoS One [Internet]. [cited 2019 Nov 15];7(4):e35250. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0035250","DOI":"10.1371\/journal.pone.0035250"},{"key":"4_CR8","doi-asserted-by":"crossref","unstructured":"Banin E, Gootwine E, Obolensky A, Ezra-Elia R, Ejzenberg A, Zelinger L, et al (2015) Gene augmentation therapy restores retinal function and visual behavior in a sheep model of CNGA3 achromatopsia. Mol Ther [Internet]. [cited 2022 Feb 16];23(9):1423\u201333. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26087757\/","DOI":"10.1038\/mt.2015.114"},{"issue":"MAY","key":"4_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00292","volume":"11","author":"R M\u00fchlfriedel","year":"2017","unstructured":"M\u00fchlfriedel R, Tanimoto N, Sch\u00f6n C, Sothilingam V, Garrido MG, Beck SC et al (2017) AAV-mediated gene supplementation therapy in achromatopsia type 2: preclinical data on therapeutic time window and long-term effects. Front Neurosci 11(MAY):292","journal-title":"Front Neurosci"},{"key":"4_CR10","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013392","volume":"13","author":"M Pavlou","year":"2021","unstructured":"Pavlou M, Sch\u00f6n C, Occelli LM, Rossi A, Meumann N, Boyd RF et al (2021) Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders. EMBO Mol Med 13:e13392","journal-title":"EMBO Mol Med"},{"issue":"389","key":"4_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scisignal.aab0611","volume":"8","author":"U Scheib","year":"2015","unstructured":"Scheib U, Stehfest K, Gee CE, K\u00f6rschen HG, Fudim R, Oertner TG et al (2015) The rhodopsin-guanylyl cyclase of the aquatic fungus Blastocladiella emersonii enables fast optical control of cGMP signaling. Sci Signal 8(389):1\u20138","journal-title":"Sci Signal"},{"key":"4_CR12","doi-asserted-by":"crossref","unstructured":"Chen TW, Wardill TJ, Sun Y, Pulver SR, Renninger SL, Baohan A, et al (2013) Ultra-sensitive fluorescent proteins for imaging neuronal activity. Nature [Internet]. [cited 2023 Aug 29];499(7458):295. Available from: \/pmc\/articles\/PMC3777791\/","DOI":"10.1038\/nature12354"},{"key":"4_CR13","doi-asserted-by":"publisher","unstructured":"Wu N, Nishioka WK, Derecki NC, Maher MP (2019) High-throughput-compatible assays using a genetically-encoded calcium indicator. Sci Rep [Internet]. [cited 2021 Feb 19];9(1):1\u201317. Available from: https:\/\/doi.org\/10.1038\/s41598-019-49070-8","DOI":"10.1038\/s41598-019-49070-8"},{"key":"4_CR14","doi-asserted-by":"crossref","unstructured":"Pavlou M, Babutzka S, Michalakis S (2022) A bioengineered in vitro model to assess AAV-based gene therapies for cyclic GMP-related disorders. Int J Mol Sci [Internet]. [cited 2023 May 25];23(9):4538. Available from: https:\/\/www.mdpi.com\/1422-0067\/23\/9\/4538\/htm","DOI":"10.3390\/ijms23094538"},{"key":"4_CR15","doi-asserted-by":"publisher","unstructured":"Wilson MH, Coates CJ, George AL Jr (2007) PiggyBac transposon-mediated gene transfer in human cells. Mol Ther 15(1):139\u201345. https:\/\/doi.org\/10.1038\/sj.mt.6300028. PMID: 17164785","DOI":"10.1038\/sj.mt.6300028"},{"key":"4_CR16","doi-asserted-by":"publisher","unstructured":"Das AT, Tenenbaum L, Berkhout B (2016) Tet-on systems for doxycycline-inducible gene expression. Curr Gene Ther 16(3):156\u201367. https:\/\/doi.org\/10.2174\/1566523216666160524144041. PMID: 27216914","DOI":"10.2174\/1566523216666160524144041"},{"key":"4_CR17","doi-asserted-by":"publisher","unstructured":"Dana H, Mohar B, Sun Y, Narayan S, Gordus A, Hasseman JP, Tsegaye G, Holt GT, Hu A, Walpita D, Patel R, Macklin JJ, Bargmann CI, Ahrens MB, Schreiter ER, Jayaraman V, Looger LL, Svoboda K, Kim DS (2016) Sensitive red protein calcium indicators for imaging neural activity. Elife 5:e12727. https:\/\/doi.org\/10.7554\/eLife.12727. PMID: 27011354","DOI":"10.7554\/eLife.12727"}],"container-title":["Methods in Molecular Biology","Retinal Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5198-8_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:03:45Z","timestamp":1776899025000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5198-8_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071651971","9781071651988"],"references-count":17,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5198-8_4","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 April 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}